Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications (English, HTML)
View metadata and access the original English HTML file: Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2022-06-07
Pharmacometrics is the science of using quantitative analysis and modelling and simulation (M&S) approaches to inform and enhance drug development and regulatory review. Pharmacometrics also encompasses quantitative system pharmacology and model-informed drug development (MIDD) approaches.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file